Top Markets
Coin of the day
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Rankning i aktier #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Aktiekurs
$0.07600875
Senast synkroniserad: 2024-11-20
Marknadsvärde
$2.06M
Förändring (1 dag)
-0.51%
Förändring (1 år)
0.00%
Land
FR
Handel Quantum Genomics S.A. (ALQGC)

Kategori

Historik för aktiesplit för Quantum Genomics S.A. (ALQGC)
Aktien Quantum Genomics S.A. (symbol: ALQGC) har genomgått totalt 1 aktiesplitar.
Den senaste spliten skedde den Dec 13, 2013.
En ALQGC-aktie köpt före Dec 13, 2013 motsvarar nu 0.055555555555556 ALQGC-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2013-12-13 1:18 x0.055555555555556 x0.055555555555556
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE